Source: Romero-Mendoza, M., Peláez-Ballestas, I., Almanza-Avendaño, A.M. et al. Structural violence and the need for compassionate use of methadone in Mexico. BMC Public Health 22, 606 (2022). https://doi.org/10.1186/s12889-022-12955-x Abstract Background Epidemiological data from Mexico have...

Source: Ospina-Escobar, A., & Magis-Rodríguez, C. (2022). Transition from first illegal drug use to first injection among people who inject drugs in Northern Mexico: A retrospective survival analysis. Salud Mental, 45(2), 71-80. doi:https://doi.org/10.17711/SM.0185-3325.2022.010 Abstract...

Source: L.Driscoll, D., Cuellar, A.E., Agarwal, V. et al. Promoting sustainable responses to the US opioid epidemic with community-academic partnerships: qualitative outcomes from a statewide program. Subst Abuse Treat Prev Policy 17, 26 (2022). https://doi.org/10.1186/s13011-022-00454-6 Abstract...

Source: Dietze, P., Gerra, G., Poznyak, V., Campello, G., Kashino, W., Dzhonbekov, D., Kiriazova, T., Nikitin, D., Terlikbayeva, A., Krupchanka, D., & Busse, A. (2022). An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine...

Source: Yunusa I, Gagne JJ, Yoshida K, Bykov K. Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors. JAMA Netw Open. 2022;5(2):e220194. doi:10.1001/jamanetworkopen.2022.0194 Key Points Question Is concomitant use of oxycodone with...

Source: Ericson, Ø.B., Eide, D., Lobmaier, P. et al. Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional study. Subst Abuse Treat Prev Policy 17, 13 (2022). https://doi.org/10.1186/s13011-022-00440-y Abstract Background During the...

Fuente: Currie JM, Schnell MK, Schwandt H, Zhang J. Prescripción de analgésicos opioides y buprenorfina para el trastorno por uso de opioides durante la pandemia de COVID-19. JAMA Netw Open. 2021;4(4):e216147. doi:10.1001/jamanetworkopen.2021.6147 Puntos clave Pregunta ¿Cómo ha cambiado la...

Source: Thakrar AP, Alexander GC, Saloner B. Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021. JAMA Netw Open. 2021;4(12):e2138807. doi:10.1001/jamanetworkopen.2021.38807 Discussion In the US, buprenorphine use increased substantially in correctional settings during the past 5...

Source: Levander, X.A., Hoffman, K.A., McIlveen, J.W. et al. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis. Addict Sci Clin Pract 16, 72 (2021). https://doi.org/10.1186/s13722-021-00281-3 Abstract Background...

Fuente: https://www1.nyc.gov/assets/doh/downloads/pdf/public/supervised-injection-report.pdf Publicado 05/03/2018 Las muertes por sobredosis en la ciudad de Nueva York han aumentado constantemente en los últimos 15 años, creciendo hasta la crisis que ahora enfrentamos. En 2017, los datos...

Source: Frost, M.C., Lampert, H., Tsui, J.I. et al. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract 16, 62 (2021). https://doi.org/10.1186/s13722-021-00266-2 Abstract Background Methamphetamine...

Source: Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128 Key Points Question Is high-dose (>12 mg) buprenorphine induction safe and...

Source: Hser, YI., Ober, A.J., Dopp, A.R. et al. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Addict Sci Clin Pract 16, 24 (2021)...

Source: Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9 Abstract Background Patients with opioid use disorder...

Source: Kelley, A.T., Smid, M.C., Baylis, J.D. et al. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addict Sci Clin Pract 16, 40 (2021). https://doi.org/10.1186/s13722-021-00246-6 Abstract...

Source: Garland, E. L., Atchley, R. M., Hanley, A. W., Zubieta, J. K., & Froeliger, B. (2019). Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Science advances, 5(10), eaax1569. Abstract Addiction...

Source: Lintzeris N, Dunlop AJ, Haber PS, et al. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(5):e219041. doi:10.1001/jamanetworkopen.2021.9041 Key Points...

Source: Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021-00378-7 Abstract Background A lack of conceptual modeling of...

Los medicamentos para la sobredosis, la abstinencia y la adicción a los opioides Esta infografía ilustra los distintos tipos de medicamentos que se recetan para la sobredosis, la abstinencia y la adicción a los opioides. Medicamentos para la sobredosis, la abstinencia y la adicción a los opioides...

Medications for Opioid Use Disorder Infographic This infographic shows the different types of medications prescribed for opioid overdose, withdrawal, and addiction. Medications for opioid overdose, withdrawal, and addiction Medications for opioid overdose, withdrawal, and addiction are safe...